COVID-19 is more severe in patients with hypertension; ACEI/ARB treatment does not influence clinical severity and outcome

Jianhua Hu,Xiaoli Zhang,Xuan Zhang,Hong Zhao,Jiangshan Lian,Shaorui Hao,Hongyu Jia,Meifang Yang,Yingfeng Lu,Dairong Xiang,Huan Cai,Shanyan Zhang,Jueqing Gu,Chanyuan Ye,Guodong Yu,Ciliang Jin,Lin Zheng,Yida Yang,Jifang Sheng

Journal of Infection（2020）

引用 37|浏览0

暂无评分

关键词

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2),Coronavirus disease 2019 (COVID-19),Hypertention,Angiotensin-converting enzyme inhibitor (ACEI),Angiotensin receptor blocker (ARB),Outcome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要